1. Home
  2. NTRA vs TRGP Comparison

NTRA vs TRGP Comparison

Compare NTRA & TRGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$272.94

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Logo Targa Resources Inc.

TRGP

Targa Resources Inc.

N/A

Current Price

$278.31

Market Cap

56.8B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
TRGP
Founded
2003
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
56.7B
56.8B
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
NTRA
TRGP
Price
$272.94
$278.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
23
22
Target Price
★ $412.36
$333.48
AVG Volume (30 Days)
★ 2.0M
1.2M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 1.75%
EPS Growth
0.65
★ 47.91
EPS
N/A
★ 8.79
Revenue
$210,939,000.00
★ $17,028,300,000.00
Revenue This Year
$30.72
$14.52
Revenue Next Year
$21.67
$20.67
P/E Ratio
★ N/A
$32.47
Revenue Growth
N/A
★ 3.95
52 Week Low
$181.00
$167.12
52 Week High
$437.41
$316.60

Technical Indicators

Market Signals
Indicator
NTRA
TRGP
Relative Strength Index (RSI) 24.66 43.12
Support Level $254.83 $272.07
Resistance Level $288.04 $296.88
Average True Range (ATR) 19.03 10.22
MACD -7.70 -0.82
Stochastic Oscillator 1.47 45.76

Price Performance

Historical Comparison
NTRA
TRGP

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About TRGP Targa Resources Inc.

Targa Resources Corp is a midstream firm that mainly operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset. It has two operating segments: Gathering and Processing, and, Logistics and Transportation (also referred to as the Downstream Business).

Share on Social Networks: